Melanotan II and skin cancer: separating hype from actual risk

What did @alphaclubsupps actually say?

The creator's core argument is reasonable on the surface: MT2 doesn't directly cause skin cancer, it just "darkens moles and therefore they become far more difficult to detect changes in those moles." He frames the cancer concern as a detection problem, not a biological one. He also says MT1 and MT2 were "designed to protect you from skin cancer" by increasing melanin, which reduces burning and UV damage. Credit where it's due: he's trying to add nuance to a black-and-white narrative. But nuance done sloppily can be just as misleading as the fear-mongering he's criticizing.

He's also casually disclosing personal use: "I've been taking it for the last couple of months and fucking it's brilliant." That's not a clinical endorsement, but it frames the video as advocacy, which shapes how the science gets presented.

Does the science back this up?

Partly, but the creator significantly understates the actual risk picture. Melanotan II is a synthetic analog of alpha-melanocyte stimulating hormone (alpha-MSH). It does stimulate melanogenesis, and higher baseline melanin does correlate with reduced UV-induced DNA damage in fair-skinned individuals. That part is real. The original University of Arizona research in the 1980s and 1990s, led by Mac Hadley and Victor Hruby, was genuinely aimed at photoprotection.

But the mole-darkening issue is not just a detection problem. Multiple case reports document new melanocytic nevi appearing after melanotan use, and existing nevi changing in ways consistent with dysplasia, not just pigmentation shifts. A 2009 case series published in the Journal of the American Academy of Dermatology (Dawson et al.) documented mole changes requiring biopsy following melanotan use. A 2018 case report in Clinical and Experimental Dermatology (Hughes et al.) linked melanotan II use to a melanoma diagnosis in a 26-year-old. These are case reports, not randomized trials, but they describe biological changes, not just visual obscuration.

The deeper concern is that melanocortin receptor activation, specifically MC1R, plays a role in melanocyte proliferation pathways. Driving those pathways in a person with pre-existing atypical nevi isn't equivalent to just getting a tan.

What did they get wrong (or right)?

He got the basic biology directionally correct: melanin does provide some photoprotection, and the detection-difficulty argument is a real and documented concern. Dermatologists have flagged that mole mapping becomes less reliable after melanotan use, and that's a legitimate clinical issue worth raising.

Where he goes wrong is collapsing the entire risk picture into a single mechanism. Saying "it's not MT1 and MT2 directly give you skin cancer, it's just" detection difficulty is an oversimplification that lets the peptide off the hook too easily. The existing case literature suggests the relationship between MC1R agonism and melanocyte behavior is more complicated than "melanin good, no burn, no cancer."

He also compares the concern to fear-mongering around testosterone and GLP-1s, which is a rhetorical move, not an argument. Those are not equivalent risk profiles. Melanotan II has no approved human use in any major regulatory jurisdiction. The FDA, EMA, and MHRA have all issued warnings against it. That's worth mentioning when you're telling 118,000 people not to be put off by the risk narrative.

What should you actually know?

If you're considering melanotan II, the detection problem alone should give you pause. Regular skin checks are a primary tool for catching melanoma early, when it's most treatable. If a compound systematically changes the appearance of your moles, you've just made that tool less reliable, regardless of whether the peptide itself is carcinogenic.

The broader point is that "no direct causation proven" is not the same as "safe." Melanotan II has never completed Phase III clinical trials. The University of Arizona team shelved it partly due to side effect concerns including nausea, spontaneous erections, and cardiovascular effects. What's being sold online is unregulated, often dosed without standardization, and injected without medical supervision.

Anyone using this compound should be under the care of a dermatologist who knows about the use and is doing baseline mole mapping. That's not fear-mongering. That's just the minimum reasonable precaution when you're activating melanocyte pathways with a synthetic hormone analog that regulators in multiple countries have warned against.